← Back to Screener
SIGA Technologies Inc. (SIGA)
Price$4.30
Value ScoreB
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-36.97%
Price vs S&P 500 (4W)-10.41%
VGM Score41.99
Market Capitalization$309.13M
P/E Ratio (Annual)13.28x
Indicated Dividend Yield (Annual)0.00%
All Metrics
P/CF (Annual)7.11x
Book Value / Share (Quarterly)$2.11
P/TBV (Annual)20.08x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-5.14%
Cash Flow / Share (Quarterly)$0.38
Payout Ratio (TTM)120.81%
Price vs S&P 500 (YTD)-37.78%
Gross Margin (TTM)65.36%
Net Profit Margin (TTM)21.58%
EPS (TTM)$0.28
10-Day Avg Trading Volume0.40M
EPS Excl Extra (TTM)$0.28
Revenue Growth (5Y)-5.43%
EPS (Annual)$0.32
Dividend / Share (Annual)$0.60
ROI (Annual)11.71%
Gross Margin (Annual)68.59%
Net Profit Margin (5Y Avg)39.71%
Cash / Share (Quarterly)$2.03
P/E Basic Excl Extra (TTM)15.28x
Revenue Growth QoQ (YoY)-11.34%
EPS Growth (5Y)-14.51%
P/E Normalized (Annual)13.28x
ROA (Last FY)10.61%
Revenue Growth TTM (YoY)-22.07%
EBITD / Share (TTM)$0.30
ROE (5Y Avg)26.70%
Operating Margin (TTM)22.01%
Cash Flow / Share (Annual)$0.60
P/B Ratio2.04x
P/B Ratio (Quarterly)2.53x
Net Income / Employee (Annual)$475,100
EV / Revenue (TTM)1.74x
Net Interest Coverage (TTM)12.31x
ROA (TTM)8.94%
EV / EBITDA (TTM)7.71x
EPS Incl Extra (Annual)$0.32
Current Ratio (Annual)11.83x
Quick Ratio (Quarterly)2.30x
3-Month Avg Trading Volume0.60M
52-Week Price Return-26.87%
EV / Free Cash Flow (Annual)3.79x
P/E Incl Extra (TTM)15.28x
Revenue / Employee (TTM)$1,913,800
Tangible BV / Share (Quarterly)$0.15
P/S Ratio (Annual)3.27x
Asset Turnover (Annual)0.43x
52-Week High$9.62
Operating Margin (5Y Avg)48.09%
EPS Excl Extra (Annual)$0.32
CapEx CAGR (5Y)77.76%
Tangible BV CAGR (5Y)19.88%
26-Week Price Return-29.04%
Quick Ratio (Annual)8.79x
13-Week Price Return-31.09%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.25x
Enterprise Value$163.57M
Revenue / Share Growth (5Y)-3.52%
Asset Turnover (TTM)0.41x
Book Value / Share Growth (5Y)10.55%
Revenue / Employee (Annual)$1,930,100
Inventory Turnover (Annual)0.60x
Pretax Margin (Annual)32.12%
Cash / Share (Annual)$2.16
3-Month Return Std Dev50.63%
Gross Margin (5Y Avg)82.36%
Net Income / Employee (TTM)$412,900
EBITDA CAGR (5Y)-21.23%
ROE (Last FY)11.71%
Net Interest Coverage (Annual)70.15x
EPS Basic Excl Extra (Annual)$0.32
P/FCF (TTM)2.44x
Receivables Turnover (TTM)16.05x
EV / Free Cash Flow (TTM)5.97x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.28
Receivables Turnover (Annual)7.74x
ROI (TTM)10.60%
P/S Ratio (TTM)3.30x
Pretax Margin (5Y Avg)51.26%
Revenue / Share (Annual)$1.32
Tangible BV / Share (Annual)$0.15
Forward P/E7.90x
Free OCF CAGR (5Y)-9.62%
Price vs S&P 500 (52W)-51.24%
P/E Ratio (TTM)15.28x
EPS Growth TTM (YoY)-58.42%
Year-to-Date Return-29.62%
5-Day Price Return-3.15%
EPS Normalized (Annual)$0.32
ROA (5Y Avg)22.27%
Net Profit Margin (Annual)24.61%
Month-to-Date Return-8.12%
Cash Flow / Share (TTM)$-0.06
EBITD / Share (Annual)$0.34
EPS Growth (3Y)-11.11%
Operating Margin (Annual)25.06%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)11.14x
ROI (5Y Avg)26.70%
P/E Excl Extra (TTM)15.28x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.28
P/TBV (Quarterly)20.08x
Payout Ratio (Annual)185.22%
P/B Ratio (Annual)2.20x
Dividend / Share (TTM)$0.60
Inventory Turnover (TTM)0.56x
Pretax Margin (TTM)28.69%
Book Value / Share (Annual)$2.78
Price vs S&P 500 (13W)-39.34%
Net Margin Growth (5Y)-11.39%
Dividend Yield (TTM)14.00%
Beta0.88x
P/FCF (Annual)7.17x
Revenue / Share (TTM)$1.31
ROE (TTM)10.60%
52-Week Low$4.10
vGradeB
gGradeD
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.05est. —
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SIGASIGA Technologies Inc. | B | D | D | $4.30 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
SIGA Technologies is a commercial-stage pharmaceutical company focused on health security solutions. Its flagship product, TPOXX, is an oral antiviral treatment for human smallpox caused by the variola virus. The company derives its revenue primarily from the United States market.